1980
DOI: 10.1073/pnas.77.3.1311
|View full text |Cite
|
Sign up to set email alerts
|

Transforming gene product of Rous sarcoma virus phosphorylates tyrosine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

47
1,170
2
5

Year Published

1989
1989
2006
2006

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 2,157 publications
(1,224 citation statements)
references
References 32 publications
47
1,170
2
5
Order By: Relevance
“…MK-801 is a potent and selective antagonist of the NMDA type of glutamate receptors which bind to the ion channel of the receptor complex [4,5]. To further confirm that the protective effect of MK-801 is mediated by its action on the NMDA type of glutamate receptors, we assessed the effect of another specific antagonist, AP-5, which acts on a dif'ferent site (the glutamate binding site) of the same receptor.…”
Section: Resultsmentioning
confidence: 99%
“…MK-801 is a potent and selective antagonist of the NMDA type of glutamate receptors which bind to the ion channel of the receptor complex [4,5]. To further confirm that the protective effect of MK-801 is mediated by its action on the NMDA type of glutamate receptors, we assessed the effect of another specific antagonist, AP-5, which acts on a dif'ferent site (the glutamate binding site) of the same receptor.…”
Section: Resultsmentioning
confidence: 99%
“…This is supported by our ®nding of low levels of both GFAP and v-src RNA also in Schwann cells of peripheral nerves, which were probably the source of the signals detected in extracerebral tissues by RT ± PCR (JPS, JW and AA, unpublished data). The transforming activity of the viral Src oncoprotein (Collett and Erikson, 1978) is dependent on its kinase activity and hence on its ability to phosphorylate speci®c cellular proteins at tyrosine residues (Hunter and Sefton, 1980). The absence of a pathological phenotype in line src3 can be explained by the observation of a truncated v-src.…”
Section: Discussionmentioning
confidence: 99%
“…Aliquots of the anti-JAK2 immunoprecipitated material were then subjected to in vitro radiolabelling autokinase assays, which provide a basic measure of JAK2's enzymatic activity [33][34][35]. No detectable activity was associated with the kinaseinactive EGFP/rJAK2(K882E), as anticipated.…”
Section: Characteristics Of the Egfp/rjak2 Chimeras Produced In Cos-7mentioning
confidence: 99%